BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 169278)

  • 21. Abnormal regulation of antidiuretic hormone in idiopathic edema.
    Thibonnier M; Marchetti J; Corvol P; Menard J; Milliez P
    Am J Med; 1979 Jul; 67(1):67-73. PubMed ID: 463918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of upright posture and isoproterenol infusion on cyclic adenosine monophosphate excretion in control subjects and patients with labile hypertension.
    Hamet P; Kuchel O; Genest J
    J Clin Endocrinol Metab; 1973 Feb; 36(2):218-26. PubMed ID: 4345690
    [No Abstract]   [Full Text] [Related]  

  • 23. [Idiopathic cyclic edema: disorders in water elimination accentuated by orthostasis].
    Zech P; Pozet N; Carreras-Berges L
    Nouv Presse Med; 1977 Apr; 6(13):1121-4. PubMed ID: 850623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary excretion and circadian rhythm of cyclic-AMP and cyclic-GMP in childhood.
    Castellote MC; Barberá G; Torralba A
    Rev Esp Fisiol; 1981 Dec; 37(4):403-6. PubMed ID: 6280254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Urinary excretion of calcium and cyclic adenosine monophosphate in children. Comparison between the two variables].
    Mougin C; Henriet MT; Nguyen NU; Dumoulin G; Berthelay S
    C R Seances Soc Biol Fil; 1982; 176(3):319-23. PubMed ID: 6290003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Plasma level and urinary excretion of adnosine 3'5'-monophosphate (cycl AMP) in normal subjects].
    Czekalski S; Eder M; Gryczyńska M
    Endokrynol Pol; 1975; 26(5):517-24. PubMed ID: 176023
    [No Abstract]   [Full Text] [Related]  

  • 27. Urinary excretion of cyclic 3',5'-adenosine monophosphate and cyclic 3',5'-guanosine monophosphate during and after pregnancy.
    Kopp L; Paradiz G; Tucci JR
    J Clin Endocrinol Metab; 1977 Mar; 44(3):590-4. PubMed ID: 190264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of chlorpropamide on renal response to parathyroid hormone in normal subjects and in patients with hypoparathyroidism and pseudohypoparathyroidism.
    Coulson R; Moses AM
    J Pharmacol Exp Ther; 1975 Sep; 194(3):603-13. PubMed ID: 169346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of cyclic 3'5'-adenosine monophosphate excretion in parathyroid dysfunction.
    Ullrich IH; Lizarralde G
    Chronobiologia; 1977; 4(3):199-204. PubMed ID: 202439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of secondary hyperparathyroidism in most patients with renal hypercalciuria.
    Olmer M; Berland Y; Argemi B
    Kidney Int Suppl; 1983 Dec; 16():S175-9. PubMed ID: 6330424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary cyclic AMP and cyclic GMP in normal and asthmatic subjects during exercise.
    Linklater HA; Strickland KP; Cunningham DA; Griffiths JC; Trevithick JR
    Med Sci Sports; 1979; 11(3):250-5. PubMed ID: 230405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal vein plasma adenosine 3',5'-cyclic monophosphate in renovascular hypertension.
    Kuchel O; Messerli FH; Tolis G; Hamet P; Fraysse J; Cartier P; Roy P; Boucher R; Genest J
    Can Med Assoc J; 1977 May; 116(9):992-6. PubMed ID: 192429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary cyclic AMP in hyperthyroidism.
    de Nutte N; Demeester-Mirkine N; Six R; Corvilain J; de Backer M
    Horm Metab Res; 1978 Jul; 10(4):315-8. PubMed ID: 210095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes in the circadian rhythm of urinary cyclic adenosine monophosphate during the alcoholic withdrawal syndrome and related neurobiological correlations].
    Nardoni A; Di Piazza V; Marchetti E; Geatti O; Cedaro P; Lattuada L
    Minerva Med; 1985 Sep; 76(34-35):1535-40. PubMed ID: 2993962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of catecholamines and adrenergic-blocking agents on plasma and urinary cyclic nucleotides in man.
    Ball JH; Kaminsky NI; Hardman JG; Broadus AE; Sutherland EW; Liddle GW
    J Clin Invest; 1972 Aug; 51(8):2124-9. PubMed ID: 4403383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary excretion of cyclic AMP in hyperparathyroidism.
    Wålinder O; Ljunghall S; Wibell L
    Scand J Urol Nephrol; 1978; 12(1):67-71. PubMed ID: 204993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of resistance to the phosphaturic effect of the parathyroid hormone in the hamster.
    Knox FG; Preiss J; Kim JK; Dousa TP
    J Clin Invest; 1977 Apr; 59(4):675-83. PubMed ID: 14974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal effects of adenosine 3',5'-cyclic monophosphate and dibutyryl adenosine 3',5'-cyclic monophosphate. Evidence for a role for adenosine 3',5'-cyclic monophosphate in the regulation of proximal tubular sodium reabsorption.
    Gill JR; Casper AG
    J Clin Invest; 1971 Jun; 50(6):1231-40. PubMed ID: 4326154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of parathyroid status of rats on renal tubular handling of adenosine 3'5'-monophosphate: a micropuncture study.
    Küntziger H; Cailla H; Amiel C; Delaage M
    J Cyclic Nucleotide Res; 1981; 7(5):313-9. PubMed ID: 6284818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of a diurnal plasma adenosine 3',5'-monophosphate rhythm.
    Endres P; Roeren T
    J Clin Endocrinol Metab; 1979 May; 48(5):872-3. PubMed ID: 219012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.